AMSBIO offers a comprehensive range of high quality Heparan Sulfate (HS) antibodies from F69-3G10, F58-10E4 and JM403 clones, which have been proven ideal for targeted binding of HS in Heparan Sulfate Proteoglycans (HSPG) research.Heparan Sulfate is synthesized as the glycosaminoglycan (GAG) component of Heparan Sulfate Proteoglycans. It is expressed on the cell surface of virtually all cell types and basement membranes in mammals. It displays specific interactions with many biologically active proteins and, thus, is involved in many important biological processes.Many researchers…
Cambridge, UK, 27 August 2019: Sphere Fluidics, a company commercializing single cell analysis systems underpinned by its patented picodroplet technology, today introduced an updated version of its Cyto-Mine® Studio Software Suite, a collection of software controlling operation of its Cyto-Mine Single Cell Analysis System, data acquisition and follow-up analysis. The latest software version includes new functionality to further enhance users’ workflows in biologics discovery and cell line development.Sphere Fluidics’ Cyto-Mine integrates selective screening of tens of millions of single cells…
20th August 2019: Marks & Clerk, the UK’s largest Patent and Trade Mark Attorney firm, has boosted its team in Cambridge with the promotion of two new Partners. Steven Gurney, a specialist in the pharmaceutical sector and Matthew Pinney who specialises in software and telecommunications, both join the Marks & Clerk partnership.
The firm, which alongside its office in Cambridge has bases across the UK as well as in the EU, North America and Asia, is one of Europe’s largest teams of intellectual property specialists.
Alongside promoting new Partners, the team in Cambridge has also been…
Cambridge, UK, 21 August 2019: Sphere Fluidics, a company commercializing single cell analysis systems underpinned by its patented picodroplet technology, announced today that it has opened a new office space at Granta Park in Cambridgeshire, UK. The new facilities support the Company’s accelerated expansion and accommodate its plans for further growth.
Sphere Fluidics recently closed a $4.8 million USD (£3.7 million) funding round, enabling it to hire 10 new staff to expand commercial capabilities and facilitate service and support for its Cyto-Mine® Single Cell Analysis System. Sphere…
Cambridge, UK, 20 August: PredictImmune, developers of pioneering prognostic tools for guiding treatment options and improving patient outcomes in immune-mediated diseases, is delighted to welcome Tim Rea, an investor at BGF, to its board.
Tim has been active in the venture capital and start-up ecosystem for over 20 years across a broad range of sectors, stages and geographies. He is particularly passionate about the application of new, disruptive technologies into the healthcare and life sciences ecosystems.
An investor at BGF, the UK and Ireland’s most active investor in growing businesses…
This research, which investigates the risk of drug-induced folate deficiency with HIV integrase inhibitors, was published in Drug Metabolism and Disposition (DMD)
Westbury, NY – Aug. 15, 2019 – BioIVT, a leading provider of research models and services for drug and diagnostic development, today announced that researchers in its Transporter Sciences Group have co-authored a peer-reviewed DMD paper, which investigates the inhibitory effects of a class of HIV drugs known as integrase inhibitors on folate transporter pathways.1 Previously published studies had appeared to show a correlation…
QxMD Builds on Medscape’s Point-of-Care Tools and Services
New York, NY, August 12, 2019: WebMD Health Corp., an Internet Brands company and the leader in health information services for physicians and consumers, has acquired QxMD, a Vancouver, BC-based learning technology company that delivers mobile decision point tools and personalized learning solutions for physicians and health care professionals (HCPs).
The acquisition, announced today, combines QxMD’s unrivaled online clinical calculators and other digital learning tools for HCPs with the content, reference, point-of-care and…
Kadans expands its presence in the United Kingdom by adding its second research hub in the country to its Pan-European science park portfolio.
Kadans acquired Sycamore House from GSK. It is a 9,640 sqm industrial and warehouse building, located directly adjacent to Stevenage Bioscience Catalyst (“SBC”), and the Cell and Gene Therapy Catapult Manufacturing Centre (“CGTCMC”). Kadans will redevelop and extend Sycamore House into a modern, vibrant, multi-tenanted R&D facility with expected completion mid-2021.
The building will provide grow-on space for overflowing demand from SBC and CGTCMC…
CAMBRIDGE, UK, 09 August 2019 – Start Codon, a new model of life science and healthcare business accelerator, today announced it has partnered with Clustermarket, a leading online equipment sharing and booking platform and Science Entrepreneur Club, a life sciences network, to help drive the translation of world-class life science and healthcare research into commercially successful companies. As part of the agreement, Start Codon will be co-sponsoring the Connect2Innovate Meetup on Tuesday 13th August 2019, 18:00-21:00 at The Bradfield Centre, Cambridge.
Founded in April 2019, Start Codon…